Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy

<div>Overview of exercise attendance and adherence. <sup>a</sup>Only 20 sessions were prescribed due to patient eligible for surgical resection. <sup>b</sup>Only one session per week was prescribed since week 7 to accommodate the patient’s preference. <i>A</i> + <i>G</i>, nab-paclitaxel plus gemcitabine; BL, baseline; FOLFIRI, fluorouracil, leucovorin, and irinotecan; mFOLFIRINOX, modified FOLFIRINOX (leucovorin, fluorouracil, irinotecan, and oxaliplatin); SBRT, stereotactic body radiation therapy.</div>

European Journal of Cancer Care

fig1

Figure 1

Figure 1: Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy 

Figure 1 | Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy 